Bioqual (Bioqual) COGS-to-Revenue : 0.76 (As of May. 2018)

View and export this data going back to . Start your Free Trial

What is Bioqual COGS-to-Revenue?

Bioqual's Cost of Goods Sold for the six months ended in May. 2018 was $27.16 Mil. Its Revenue for the six months ended in May. 2018 was $35.89 Mil.

Bioqual's COGS to Revenue for the six months ended in May. 2018 was 0.76.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Bioqual's Gross Margin % for the six months ended in May. 2018 was 24.31%.

Bioqual COGS-to-Revenue Historical Data

The historical data trend for Bioqual's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual COGS-to-Revenue Chart

Bioqual Annual Data

Trend

May01

May03

May04

May05

May06

May07

May10

May11

May17

May18

COGS-to-Revenue

Get a 7-Day Free Trial

0.79

0.81

0.80

0.73

0.76

Bioqual Semi-Annual Data
	May96	May97	May98	May99	May00	May01	May03	May04	May05	May06	May07	May10	May11	May17	May18
COGS-to-Revenue	Get a 7-Day Free Trial										0.79	0.81	0.80	0.73	0.76

Bioqual COGS-to-Revenue Calculation

Bioqual's COGS to Revenue for the fiscal year that ended in May. 2018 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	27.16	/	35.885
	=	0.76

Bioqual's COGS to Revenue for the quarter that ended in May. 2018 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	27.16	/	35.885
	=	0.76

Bioqual (OTCPK:BIOQ) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Bioqual's Gross Margin % for the six months ended in May. 2018 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	27.16 / 35.885
	=	24.31 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Bioqual COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bioqual's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioqual (Bioqual) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » COGS-to-Revenue

Comparable Companies

STIM VNRX PSNL PRE MDXH ENZ TTOO BNR NOTV ACRS TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

N/A

Address

9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850

Website

https://www.bioqual.com

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.

Executives

Williams Frank E Jr

other: Communication, See Remarks

2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines